Chosa Oncology AB (XSAT:CHOSA) Beginning Cash Position: kr1.79 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:CHOSA Chosa Oncology AB XSAT:CHOSA
32 GF Score
Price kr0.87
View Full Analysis

What is Chosa Oncology AB Beginning Cash Position?

Chosa Oncology AB XSAT:CHOSA 32 Beginning Cash Position is kr1.79 Mil as of Mar. 2026. GuruFocus rates XSAT:CHOSA with a GF Score™ of 32/100.

Chosa Oncology AB's Beginning Cash Position for the quarter that ended in Mar. 2026 was kr1.79 Mil.

Chosa Oncology AB's quarterly Beginning Cash Position declined from Sep. 2025 (kr6.16 Mil) to Dec. 2025 (kr-2.00 Mil) but then increased from Dec. 2025 (kr-2.00 Mil) to Mar. 2026 (kr1.79 Mil).

Chosa Oncology AB's annual Beginning Cash Position increased from Dec. 2023 (kr0.97 Mil) to Dec. 2024 (kr8.77 Mil) but then declined from Dec. 2024 (kr8.77 Mil) to Dec. 2025 (kr6.44 Mil).

Chosa Oncology AB Beginning Cash Position Related Terms

Chosa Oncology AB Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Chosa Oncology AB's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chosa Oncology AB Beginning Cash Position Chart

Chosa Oncology AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.53 -1.43 0.97 8.77 6.44

Chosa Oncology AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.44 3.40 6.16 -2.00 1.79
XSAT:CHOSA
32GF Score
Chosa Oncology AB XSAT:CHOSA
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chosa Oncology AB Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of kr1.79 Mil mean?
Chosa Oncology AB (XSAT:CHOSA) has a Beginning Cash Position of kr1.79 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Chosa Oncology AB and its competitors.
Is Chosa Oncology AB's Beginning Cash Position too high?
Chosa Oncology AB's current Beginning Cash Position is kr1.79 Mil. Overall, Chosa Oncology AB has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Chosa Oncology AB's Beginning Cash Position compare to VRTX and REGN?
Chosa Oncology AB's Beginning Cash Position of kr1.79 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Chosa Oncology AB and its competitors. Chosa Oncology AB's current Beginning Cash Position is kr1.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chosa Oncology AB stock overvalued right now?
Chosa Oncology AB (XSAT:CHOSA) has a current Beginning Cash Position of kr1.79 Mil. The current Beginning Cash Position is kr1.79 Mil. Chosa Oncology AB's overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Chosa Oncology AB (XSAT:CHOSA), the current Beginning Cash Position is kr1.79 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chosa Oncology AB Business Description

Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Chosa Oncology AB is a biotechnology company engaged in the research and development in immunotherapy on therapeutic cancer vaccines.
32GF Score

Get the complete analysis for XSAT:CHOSA

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.87
Price